IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about General Updates
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IOL Chemicals has expanded its Ethyl Acetate manufacturing capacity from 1,00,000 MTPA to 1,20,000 MTPA, adding 20,000 MTPA at a capex of about Rs 4 crore. It has also expanded Acetic Anhydride capacity from 25,000 MTPA to 32,000 MTPA, adding 7,000 MTPA at a capex of about Rs 5.71 crore. Both expansions were funded entirely through internal accruals and were completed on 2nd March 2026. The existing facilities were already running at near-full utilization (100% for Ethyl Acetate and above 90% for Acetic Anhydride), indicating strong demand. The company stated the expansions are aimed at meeting sustained demand growth, improving margin realization through better operating leverage, and optimizing captive usage and merchant sales.
Positive for shareholders — brownfield expansions at already high-utilization plants signal strong demand and future revenue growth, while the small, internally-funded capex (under Rs 10 crore combined) means no debt or equity dilution. Likely a mild positive for the stock, reflecting operational efficiency and growth momentum.